Lisa Westerdahl

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden.